Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array.
Ontology highlight
ABSTRACT: An important precondition for the successful development of diagnostic assays of cerebrospinal fluid (CSF) biomarkers of age-related neurodegenerative diseases is an understanding of the dynamic nature of the CSF proteome during the normal aging process. In this study, a novel proteomic technology was used to quantify hundreds of proteins simultaneously in the CSF from 90 cognitively normal adults 21 to 85 years of age. SomaLogic's highly multiplexed proteomic platform can measure more than 800 proteins simultaneously from small volumes of biological fluids using novel slow off-rate modified aptamer (SOMAmer) protein affinity reagents with sensitivity, specificity, and dynamic ranges that meet or exceed those of enzyme-linked immunosorbent assays. In the first application of this technolog
SUBMITTER: Baird GS
PROVIDER: S-EPMC3349859 | biostudies-literature | 2012 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA